Inhibikase Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SANDS CAPITAL VENTURES, LLC | 11/13/2025 | 10.95 M | $17.74 M | 0.00% | 12.17% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 6.33 M | $10.25 M | 0.00% | 7.03% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 11/14/2025 | 6.13 M | $9.92 M | 0.00% | 6.80% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 5.42 M | $8.78 M | -0.20% | 6.02% |
| COMMODORE CAPITAL LP | 11/14/2025 | 5.40 M | $8.74 M | 0.00% | 6.00% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 5.25 M | $8.50 M | 2.45% | 5.83% |
| VANGUARD GROUP INC | 11/07/2025 | 3.27 M | $5.30 M | 1.52% | 3.64% |
| BLACKROCK, INC. | 11/12/2025 | 3.08 M | $4.98 M | 12.72% | 3.42% |
| BLACKSTONE INC. | 11/14/2025 | 2.64 M | $4.27 M | 0.00% | 2.93% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 2.19 M | $3.55 M | 0.00% | 2.43% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.11 M | $1.80 M | 4.30% | 1.24% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 11/13/2025 | 735.02 K | $1.19 M | 0.17% | 0.82% |
| STATE STREET CORP | 11/14/2025 | 507.75 K | $822.55 K | 27.64% | 0.56% |
| NORTHERN TRUST CORP | 11/14/2025 | 374.34 K | $606.42 K | -4.68% | 0.42% |
| BLAIR WILLIAM & CO/IL | 11/12/2025 | 152.95 K | $247.78 K | -2.55% | 0.17% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 152.30 K | $246.72 K | 0.00% | 0.17% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 138.67 K | $224.64 K | 4.68% | 0.15% |
| UBS GROUP AG | 11/13/2025 | 136.28 K | $220.77 K | 252.38% | 0.15% |
| FMR LLC | 11/13/2025 | 105.77 K | $171.35 K | -26.67% | 0.12% |
| BARCLAYS PLC | 11/12/2025 | 85.58 K | $138.64 K | -22.38% | 0.10% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 80.50 K | $130.40 K | 100.00% | 0.09% |
| NUVEEN, LLC | 11/12/2025 | 78.66 K | $127.43 K | 0.00% | 0.09% |
| CITADEL ADVISORS LLC | 11/14/2025 | 71.67 K | $116.11 K | 100.00% | 0.08% |
| RHUMBLINE ADVISERS | 11/06/2025 | 57.55 K | $93.23 K | -1.66% | 0.06% |
| MORGAN STANLEY | 11/14/2025 | 56.02 K | $90.75 K | -43.80% | 0.06% |
| JPMORGAN CHASE & CO | 11/26/2025 | 49.94 K | $80.90 K | 74.73% | 0.06% |
| NEW YORK STATE COMMON RETIREMENT FUND | 11/03/2025 | 47.90 K | $77.60 K | -21.09% | 0.05% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 45.75 K | $74.11 K | 19.36% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 45.61 K | $73.88 K | -88.09% | 0.05% |
| INVESCO LTD. | 11/13/2025 | 33.03 K | $53.52 K | 7.56% | 0.04% |
| INTECH INVESTMENT MANAGEMENT LLC | 11/12/2025 | 31.92 K | $51.71 K | 1.63% | 0.04% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 30.61 K | $50.00 K | 0.00% | 0.03% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2025 | 27.96 K | $45.30 K | -15.32% | 0.03% |
| POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 11/12/2025 | 17.64 K | $28.57 K | 0.00% | 0.02% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 17.10 K | $27.71 K | -11.00% | 0.02% |
| CAXTON CORP | 11/14/2025 | 16.39 K | $26.56 K | 0.00% | 0.02% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 15.64 K | $25.34 K | 70.33% | 0.02% |
| VIRTU FINANCIAL LLC | 11/14/2025 | 13.45 K | $22.00 K | 100.00% | 0.01% |
| VOYA INVESTMENT MANAGEMENT LLC | 10/09/2025 | 13.15 K | $21.30 K | -29.91% | 0.01% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 10.74 K | $17.39 K | 100.00% | 0.01% |
| BUCKINGHAM STRATEGIC PARTNERS | 11/12/2025 | 10.71 K | $17.35 K | 0.00% | 0.01% |
| PROSHARE ADVISORS LLC | 11/06/2025 | 10.34 K | $16.75 K | -16.61% | 0.01% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2025 | 7.70 K | $12.48 K | 100.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 7.05 K | $11.42 K | 6,946.00% | 0.01% |
| AMERITAS INVESTMENT PARTNERS, INC. | 11/10/2025 | 6.17 K | $10.00 K | 0.00% | 0.01% |
| LEGAL & GENERAL GROUP PLC | 11/13/2025 | 5.50 K | $8.89 K | 0.00% | 0.01% |
| STERLING CAPITAL MANAGEMENT LLC | 11/12/2025 | 3.83 K | $6.20 K | 154.29% | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 11/14/2025 | 3.78 K | $6.12 K | 0.08% | 0.00% |
| AMALGAMATED BANK | 10/29/2025 | 2.07 K | $3.00 K | 0.00% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 902 | $1.46 K | -95.58% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Inhibikase Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 57 institutional investors and hedge funds held shares of Inhibikase Therapeutics, Inc.. The most heavily invested institutionals were:
Sands Capital Ventures, LLC: 10.95 M
Soleus Capital Management, L.P.: 6.33 M
Fairmount Funds Management LLC: 6.13 M
PERCEPTIVE ADVISORS LLC: 5.42 M
COMMODORE CAPITAL LP: 5.4 M
ADAR1 Capital Management, LLC: 5.25 M
61.07% of Inhibikase Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 56.00 M shares in the last 24 months. This purchase volume represents approximately $92.95 M in transactions.